The Japan Times - First Covid vaccine side-effect claims land in German courts

EUR -
AED 3.81801
AFN 75.371634
ALL 99.14857
AMD 408.819458
ANG 1.872922
AOA 951.202912
ARS 1104.013605
AUD 1.667682
AWG 1.871219
AZN 1.765088
BAM 1.940171
BBD 2.098297
BDT 126.262898
BGN 1.955736
BHD 0.391731
BIF 3078.020036
BMD 1.039566
BND 1.39407
BOB 7.181256
BRL 6.073562
BSD 1.039229
BTN 90.553984
BWP 14.344655
BYN 3.400408
BYR 20375.490708
BZD 2.087494
CAD 1.501409
CDF 2983.554285
CHF 0.935334
CLF 0.02581
CLP 990.435775
CNY 7.574433
CNH 7.589054
COP 4295.745994
CRC 525.963142
CUC 1.039566
CUP 27.548495
CVE 110.193873
CZK 24.987418
DJF 184.751699
DKK 7.458471
DOP 64.905271
DZD 140.216518
EGP 52.652766
ERN 15.593488
ETB 131.972953
FJD 2.436378
FKP 0.818939
GBP 0.825124
GEL 2.90562
GGP 0.818939
GHS 16.109207
GIP 0.818939
GMD 75.094988
GNF 8993.932207
GTQ 8.019017
GYD 216.979245
HKD 8.08513
HNL 26.587919
HRK 7.533523
HTG 136.74815
HUF 394.709863
IDR 17010.318936
ILS 3.724411
IMP 0.818939
INR 90.600596
IQD 1360.980242
IRR 43757.820914
ISK 143.864895
JEP 0.818939
JMD 163.840119
JOD 0.736991
JPY 155.919261
KES 134.509084
KGS 91.17488
KHR 4170.806593
KMF 486.418103
KPW 935.604123
KRW 1490.355278
KWD 0.320517
KYD 0.860025
KZT 521.799702
LAK 22522.589596
LBP 93179.203461
LKR 307.326051
LRD 207.24627
LSL 19.121298
LTL 3.069568
LVL 0.628823
LYD 5.07021
MAD 10.29681
MDL 19.378753
MGA 4896.48563
MKD 60.970735
MMK 2181.931576
MNT 3605.168847
MOP 8.323332
MRU 41.482897
MUR 48.282168
MVR 16.039866
MWK 1800.860733
MXN 21.280277
MYR 4.603366
MZN 66.412691
NAD 19.121298
NGN 1558.652081
NIO 38.237778
NOK 11.691896
NPR 145.028904
NZD 1.84728
OMR 0.400251
PAB 1.039566
PEN 3.823118
PGK 4.198165
PHP 60.17576
PKR 290.696818
PLN 4.089036
PYG 8208.544926
QAR 3.783786
RON 4.92134
RSD 115.873339
RUB 90.220663
RWF 1460.643453
SAR 3.898475
SBD 8.871648
SCR 14.957401
SDG 624.711842
SEK 11.186041
SGD 1.389629
SHP 0.826066
SLE 23.753798
SLL 21799.182004
SOS 592.696068
SRD 37.011556
STD 21516.91427
SVC 9.096244
SYP 13516.187936
SZL 19.121298
THB 35.070233
TJS 11.334545
TMT 3.648689
TND 3.285561
TOP 2.502936
TRY 37.964706
TTD 7.057026
TWD 34.083895
TZS 2716.248612
UAH 43.297397
UGX 3823.421744
USD 1.039566
UYU 44.313256
UZS 13386.650584
VES 66.469387
VND 26558.026061
VUV 128.109375
WST 2.934031
XAF 648.557471
XAG 0.033287
XAU 0.000362
XCD 2.814449
XDR 0.791306
XOF 648.557471
XPF 119.331742
YER 257.10374
ZAR 19.181565
ZMK 9357.341839
ZMW 29.491193
ZWL 334.73978
  • RBGPF

    2.2800

    67.13

    +3.4%

  • SCS

    -0.2700

    12.15

    -2.22%

  • CMSC

    -0.0700

    23.51

    -0.3%

  • BCC

    -1.5200

    102.55

    -1.48%

  • RYCEF

    1.1100

    9.13

    +12.16%

  • NGG

    -1.0900

    61.47

    -1.77%

  • RIO

    -0.8700

    60.71

    -1.43%

  • GSK

    -0.1000

    37.3

    -0.27%

  • JRI

    0.0400

    12.77

    +0.31%

  • VOD

    0.0500

    8.75

    +0.57%

  • RELX

    -0.6400

    47.61

    -1.34%

  • BTI

    -0.1500

    38.71

    -0.39%

  • CMSD

    -0.0280

    23.622

    -0.12%

  • BCE

    0.0300

    23.39

    +0.13%

  • AZN

    0.1300

    75.65

    +0.17%

  • BP

    0.4400

    33.12

    +1.33%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

M.Ito--JT